Harsh Gupta, MD
Gastroenterology · Evanston, ILNPI 1295727436
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 24.0% of the total. Reporting peaked in 2023 at $635 and has fallen 57.6% since, to $269 in 2024.
Across 161 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$625
- Takeda Pharmaceuticals U.S.A., Inc.$470
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$310
- Johnson & Johnson$248
- QOL Medical, LLC$176
- Redhill Biopharma Inc.$165
- plus $605 from 15 others
What the payments were for
- Food & beverage$2,600100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $625 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $470 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $310 |
| Johnson & Johnson | 12 | $248 |
| QOL Medical, LLC | 11 | $176 |
| Redhill Biopharma Inc. | 9 | $165 |
| Gilead | 6 | $108 |
| Evoke Pharma, Inc. | 5 | $80 |
| Ardelyx, Inc. | 3 | $55 |
| Intercept Pharmaceuticals, Inc. | 2 | $47 |
| Braintree Laboratories, Inc. | 3 | $46 |
| W. L. Gore & Associates, Inc. | 3 | $45 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $36 |
| Concordia Pharmaceuticals Inc. | 2 | $30 |
| Medtronic | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| Capsovision, Inc. | 1 | $14 |
| Merck | 1 | $12 |
How this compares
$2,600 in reported general payments places this provider in the 65th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 15 | $9,343 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 70 | $991 |
| Omeprazole | 48 | $808 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 26 | $457 |
| Pantoprazole Sodium | 37 | $398 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Evanston
- Daksesh PatelEvanston$745K
- Eugene YenEvanston$193K
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Amar NaikDes Plaines$1.2M
- Darren BrennerChicago$1.1M
- Jonathan RosenbergGurnee$1M
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.